Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-25 @ 7:05 PM
Study NCT ID:
NCT05339204
Status:
RECRUITING
Last Update Posted:
2022-04-21
First Post:
2022-04-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
Sponsor:
National Research Center for Hematology, Russia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-14
First Submit QC Date:
None
Study First Post Date:
2022-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-14
Last Update Post Date:
2022-04-21
Last Update Post Date Type:
ACTUAL